| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 3,308 | |||
| Marketable securities | 25,771 | |||
| Cash and cash equivalents | 41,214 | |||
| Total current assets | 70,293 | |||
| Restricted cash | 927 | |||
| Property and equipment, net | 1,430 | |||
| Other assets | 21 | |||
| Operating lease right-of-use assets | 14,010 | |||
| Financing lease right-of-use assets | 18 | |||
| Total assets | 86,699 | |||
| Accrued expenses and other current liabilities | 11,446 | |||
| Operating lease liabilities | 1,106 | |||
| Contract liability | 20,009 | |||
| Accounts payable | 1,551 | |||
| Total current liabilities | 34,112 | |||
| Operating lease liabilities, net of current portion | 11,331 | |||
| Total liabilities | 45,443 | |||
| Accumulated deficit | -356,104 | |||
| Common stock, 0.0001 par value 150,000,000 shares authorized at june 30, 2025 and december 31, 2024 47,730,884 shares issued as of june 30, 2025 and 40,931,085 shares issued as of december 31, 2024 and 47,686,561 shares outstanding as of june 30, 2025 and 40,886,762 shares outstanding as of december 31, 2024 | 5 | |||
| Additional paid-in capital | 397,354 | |||
| Accumulated other comprehensive income (loss) | 1 | |||
| Total stockholders' equity | 41,256 | |||
| Total liabilities and stockholders' equity | 86,699 | |||
Vigil Neuroscience, Inc. (VIGL)
Vigil Neuroscience, Inc. (VIGL)